Fresh Food Farmacy: A Randomized Controlled Trial

Clinical Trial ID: NCT03718832


This trial investigates the value created by the highly innovative Fresh Food Farmacy (FFF) program at Geisinger Health. The program provides food-insecure diabetics with healthy food for their entire household: at least two meals per day, five days a week. The program also provides education on how to prepare the food, and education on healthy living including diabetes self management. The research measures the effects of the FFF program on patient health and wellbeing.

This is a pragmatic, prospective, randomized controlled trial of Geisinger's Fresh Food Farmacy (FFF) program as the program expands to new sites. Qualifying subjects will be randomized 1:1 to receive either early participation in the FFF program (treatment group) or later participation (control group). Approximately 500 Geisinger subjects will participate in this study with about half assigned to the treatment group and about half to the control group. The treatment group will begin the program soon after trial recruitment: the "Begin Now" group. The control group will begin the program after 6 months: the "Begin Later" group. Approximately 2000 household members will be included in the data-only portion of the research. Outcomes will include clinical measures, such as HbA1c, survey responses including self-assessed health measures, and utilization / healthy-behavior measures from EHR and paid claims data. These will be measured for subjects and their household members.


Inclusion Criteria: - Type II Diabetes and an HbA1c ≥ 8.0 as determined by the most recent measurement in the Geisinger EMR within the prior 12 months - Food insecure based on a two-question survey instrument - Age > 17 & Age <86 - Living within geographic reach of the program (Lewistown, PA and Scranton, PA) Exclusion Criteria: - Already enrolled in FFF in Shamokin - Not English speaking (working on changing this as the program evolves) - On hospice or palliative care - Acute or chronic psychosis - Resides in a facility which provides meals - Active medical disorder that would preclude participation in the classes, weekly clinic visits, or result in a limited diet, including: - Cancer; active treatment - Steroid dependent asthma/ COPD/ emphysema - Steroid dependent Colitis - Chronic Kidney Disease with GFR< 30 mg/mmol - Celiac disease - Cirrhosis - Steroid dependent arthritis

  • Start Date


  • Last Updated


  • Sponsor

    Geisinger Clinic

  • Condition Name

    Type 2 Diabetes

Learn about this trial.

Check the eligibility requirements, study details, and more.

Related Trials

Different trials target different symptoms, condition types, and patients. Learn more about other emergeing treatments being investigated now.